Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
MedAdvisor Limited ( (AU:MDR) ) has shared an update.
MedAdvisor Limited announced a change in the director’s interest, with Catherine Jane Hill acquiring 500,000 fully paid ordinary shares. This acquisition, approved by shareholders at an Extraordinary General Meeting, reflects a strategic move to strengthen the director’s stake in the company, potentially impacting its governance and signaling confidence in MedAdvisor’s future prospects.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare technology industry, providing digital solutions to enhance medication management and improve health outcomes. The company focuses on developing platforms that connect patients with healthcare providers and pharmacies, facilitating better medication adherence and management.
Average Trading Volume: 879,399
Technical Sentiment Signal: Sell
Current Market Cap: A$16.45M
For detailed information about MDR stock, go to TipRanks’ Stock Analysis page.